ITGAM and melanoma: 14 days after intravenous inoculation of the melanoma cells, compared with WT mice, CD11b−/− mice had significantly reduced metastatic tumor burden measured by bioluminescence imaging analysis and less lung nodules measured by visually scoring surface tumor nodules (Figures 2A–C).